Peptide hydrogels and use thereof
AssigneesThe United State of America, as represented by the Secretary, Department of, Health and Human Services
InventorsJoel Schneider, Scott Walsh, Stephen Miller, Yuji Yamada, Scott Durum, Caroline Andrews, Wenqing Li, Julie Hixon, Steven Tau
Life of this patent
Estimating the term…
Abstract
This disclosure provides novel anionic amphiphilic β-hairpin peptides that self-assemble under appropriate conditions to form a reversible gel-sol hydrogel that can be used, for example, to readily deliver protein therapeutics and cells by injection to a target location in a subject.
Claims40
An isolated peptide, comprising or consisting of an amino acid sequence set forth as:
- (1)
- XBXZXZXBX-[DPP, DPG, or NG]-XBXZXBXBX
- wherein
- each X is independently selected from any one of L, I, T, and V;
- each B is independently selected from any one of D, E, and S;
- each Z is independently selected from any one of D, E, Q, N, T, K, R, and S;
- the DP is a proline that is a D amino acid;
- the C-terminus of the peptide is amidated or free carboxylic acid;
- the N-terminus of the peptide is acetylated or free amine;
- and
- the peptide is no more than 50 amino acids in length.
(canceled)
(canceled)
(canceled)
(canceled)
-38. (canceled)
-46. (canceled)
Dependencies are inferred from the claim text.